0001209191-22-059677.txt : 20221205 0001209191-22-059677.hdr.sgml : 20221205 20221205162121 ACCESSION NUMBER: 0001209191-22-059677 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221201 FILED AS OF DATE: 20221205 DATE AS OF CHANGE: 20221205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WIGGANS THOMAS G CENTRAL INDEX KEY: 0001208907 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40067 FILM NUMBER: 221445214 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PARDES BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001822711 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 852696306 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2173 SALK AVENUE STREET 2: SUITE 250, PMB#052 CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 415-649-8758 MAIL ADDRESS: STREET 1: 2173 SALK AVENUE STREET 2: SUITE 250, PMB#052 CITY: CARLSBAD STATE: CA ZIP: 92008 FORMER COMPANY: FORMER CONFORMED NAME: FS Development Corp. II DATE OF NAME CHANGE: 20200826 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-12-01 0 0001822711 PARDES BIOSCIENCES, INC. PRDS 0001208907 WIGGANS THOMAS G C/O PARDES BIOSCIENCES, INC. 2173 SALK AVE., SUITE 250, PMB #052 CARLSBAD CA 92008 1 1 0 0 Chief Executive Officer Common Stock 2022-12-01 4 P 0 25000 1.04 A 25000 D Common Stock 2022-12-02 4 P 0 12500 1.07 A 37500 D The price in Column 4 is a weighted average purchase price. The prices actually paid ranged from $0.96025 to $1.05. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range. The price in Column 4 is a weighted average purchase price. The prices actually paid ranged from $1.02 to $1.12. /s/ Elizabeth Lacy, attorney-in-fact 2022-12-05